Public trial registry of the CCC-Munich

Trial Leopard-II

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
Leopard-II
World
Full title
:

Definitive Radiochemotherapie mit 5-FU / Cisplatin plus/minus Cetuximab bei inoperablem, lokal fortgeschrittenem Speiseröhrenkrebs: eine Phase-II-Studie

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
Klinik f.Strahlentherapie, Telefon: 089440074521
Indications
Classification Code Description
ICD-10-GM C15.- Bösartige Neubildung des Üsophagus
- Gastrointestinal tumors
- Esophageal cancer
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
II
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2018-09-06 / 2018-09-06
Participants
Function Prename Surname Organization
World Principal Investigator CLAUS BELKA Keine Organisationseinheit angegeben Magnifier